/biz/ - Business & Finance

>>2539914

They seem in a good position, but as a pharma company that took an enormous hit earlier in the year, don't go all in if you can't afford it. God only knows when a pharma company that's been shit on will suddenly declare "ayyyyyy 1-for-10 reverse split so we have big boy price-per-share."